Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01137201
Other study ID # EPN 2009/415
Secondary ID
Status Completed
Phase N/A
First received June 2, 2010
Last updated December 2, 2015
Start date May 2010
Est. completion date November 2015

Study information

Verified date December 2015
Source University Hospital Orebro
Contact n/a
Is FDA regulated No
Health authority Sweden: The National Board of Health and WelfareSweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

To see if closing the mesenteric defects created at a Laparoscopic Gastric Bypass is better than leaving them open.


Description:

When the patients who has undergone a Laparoscopic Gastric Bypass lose weight, the mesenteric defects that are inevitable to cause, gets bigger and can cause an internal hernia (IH). This study will observe whether it is better to close the defects or leave them open. The patients will be randomized into two groups. One, where the defects are closed with sutures and one where the defects are left alone. The primary endpoint of the study is the prevalence of surgery for obstruction. Information about this will be gathered through the national register for obesity surgery in Sweden, SOReg. Each arm in the study will include 1200 patients and the follow up period will be three years. Since the register mentioned above is an ongoing register, the results can be studied over a longer period if wanted. The national hospital registry will further improve the follow-up.


Recruitment information / eligibility

Status Completed
Enrollment 2507
Est. completion date November 2015
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Any patient accepted for a Laparoscopic Gastric Bypass that has given a written consent

Exclusion Criteria:

- Conversion to open surgery prior to the randomization

- Patients not giving a written consent

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Suturing of mesenteric defects


Locations

Country Name City State
Sweden Department of Surgery, Örebro University Hospital Örebro

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Orebro

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Surgery for small bowel obstruction after a LGBP procedure. 2 years Yes
Secondary Serious Complications Defined as Clavien grade 3b or more within 2 years after surgery Yes